Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Garden State Dispatch.
Press releases published on August 11, 2025
BURRAPAY SOLIDIFIES LEADERSHIP POSITION IN COMPLIANT CRYPTOCURRENCY PAYMENT SOLUTIONS WITH U.S. PATENTS
EIN Presswire
·
August 11, 2025
Company Granted Exclusive Rights Over AML-Compliant Use of Operator Controlled Digital Currency Wallets in Regulated Gaming and Sports Book Operations MARLTON, NJ, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- BurraPay, the leading provider of …
Princeton Theological Seminary Celebrates 10 Years of the Farminary: A Decade of Cultivating Faith, Ecology, & Community
EIN Presswire
·
August 11, 2025
Four-Day Event Brings Leading Voices in Ecology, Theology, Food Justice, and More to Princeton Seminary’s 21-acre Farm PRINCETON, NJ, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- This September, Princeton Theological Seminary will celebrate the …
J & J SNACK FOODS CORP. ANNOUNCES INCREASE IN ITS QUARTERLY CASH DIVIDEND
GlobeNewswire
·
August 11, 2025
MOUNT LAUREL, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- J …
Synchronoss Technologies Reports Second Quarter 2025 Results
GlobeNewswire
·
August 11, 2025
Second Quarter Revenue of $42.5 Million, Including 92.6% Recurring Revenue Received CARES Act Tax Refund in Full, Amounting to $33.9 Million Reaffirms All Full Year Guidance Metrics BRIDGEWATER, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Synchronoss …
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 11, 2025
FDA accepts NDA submission for Anaphylm™; PDUFA date set for January 31, 2026 Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDA Company accelerates Anaphylm global expansion strategy to Canada and the EU Company to host …
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
GlobeNewswire
·
August 11, 2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP Partners and The Patel Family LLP, …
REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
GlobeNewswire
·
August 11, 2025
Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five years. WARREN, N.J., Aug. 11, 2025 ( …
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
GlobeNewswire
·
August 11, 2025
Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient accessibility. WARREN, N.J., Aug. 11, …
Montium Expands Resident Experience with Events and New Amenities
GlobeNewswire
·
August 11, 2025
Lakewood, NJ, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Montium, an owner and manager of multifamily apartment communities serving the Philadelphia metropolitan area and Lehigh Valley, is further elevating resident living with expanded community programming and …
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
GlobeNewswire
·
August 11, 2025
CRANBURY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Managed Healthcare Executive® is proud to announce the winners of the 2025 PBMI Innovators Award. These six distinguished leaders have been recognized for their outstanding contributions to advancing …
Veterinary Diagnostics Market is expected to generate a revenue of USD 4.52 Billion by 2031, Globally, at 6.59% CAGR: Verified Market Research®
GlobeNewswire
·
August 11, 2025
Lewes, Delaware, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The Global Veterinary Diagnostics Market Size is projected to grow at a CAGR of 6.59% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market …
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
GlobeNewswire
·
August 11, 2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic …
Sonnet Releases Virtual Investor "What This Means" Segment
GlobeNewswire
·
August 11, 2025
- Dr. Richard Kenney, Chief Medical Officer of Sonnet, discusses the recently announced expansion of its clinical study of patients with platinum-resistant ovarian cancer (PROC) (SB221) - Watch the "What This Means" video here PRINCETON, N.J., Aug. 11, …
New Jersey Lottery Searches For Jersey's "Top Dogs"
GlobeNewswire
·
August 11, 2025
TRENTON, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- The New Jersey Lottery today launched its “Jersey’s Top Dogs” contest, inviting pet parents across New Jersey to enter their dogs for a chance to be featured on the actual 2026 “Jersey Dog” Scratch-Offs …
Lincoln Educational Services Reports Second Quarter Results and Increases Outlook for Full Year 2025
GlobeNewswire
·
August 11, 2025
PARSIPPANY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the second quarter ended June 30, 2025, as well as recent business developments. Second Quarter …
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
GlobeNewswire
·
August 11, 2025
CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $439 million CARVYKTI® demonstrated positive long-term outcomes in CARTITUDE-1 study with one-third of patients remaining progression-free for ≥5 years Presented other …